IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain

By February 2, 2017 BioPharma No Comments

  Life Sciences Jobs   …
Source: BioSpace